IP Library Granted Patent US 7,371,408
Granted Patent B1
US 7,371,408 · App. 09/327,761 · Granted May 13, 2008

Bone graft substitute composition

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,371,408
App. No.
09/327,761
Granted
May 13, 2008
Kind
B1
Abstract

A bone graft substitute composition comprising calcium sulfate; a mixing solution selected from the group consisting of sterile water, sodium chloride, phosphate buffered saline, potassium chloride, and sodium sulfate; and a plasticizing substance selected from the group consisting of carboxymethylcellulose, polyvinyl alcohol, methycellulose, and hydroxypropyl methylcellulose.

Claims (24)

1. A bone graft substitute composition comprising:

(a) calcium sulfate;

(b) a mixing solution;

(c) a cellulose derivative plasticizing agent; and

(d) demineralized bone.

2. The bone graft substitute composition of claim 1 , comprising approximately 40% demineralized bone matrix by dry weight.

3. The bone graft substitute composition of claim 1 , wherein the mixing solution is selected from a group consisting of sterile water, an inorganic salt, and a cationic surface active agent.

4. The bone graft substitute composition of claim 3 , wherein the cationic surface agent is selected from a group consisting of sodium chloride, phosphate buffered saline, potassium chloride, sodium sulfate, ammonium sulfate, ammonium acetate, and sodium acetate.

5. The bone graft substitute composition of claim 1 , wherein the mixing solution comprises sterile water.

6. The bone graft substitute composition of claim 1 , wherein the cellulose derivative is selected from a group consisting of sodium carboxymethylcellulose, methylcellulose, hydroxypropyl methylcellulose, ethylcellulose, hydroxyethylcellulose and cellulose acetate butyrate.

7. The bone graft substitute composition of claim 1 , wherein the cellulose derivative comprises carboxymethylcellulose.

8. The bone graft substitute composition of claim 1 , wherein the calcium sulfate comprises calcium sulfate hemihydrate.

9. The bone graft substitute composition of claim 1 , wherein the calcium sulfate comprises calcium sulfate hemihydrate, the mixing solution comprises sterile water, and the cellulose derivative comprises carboxymethylcellulose.

10. The bone graft substitute composition of claim 9 , comprising approximately 100 parts calcium sulfate hemihydrate by weight, approximately 11.1 parts carboxymethylcellulose by weight, approximately 162 parts water by weight, and approximately 69.4 parts demineralized bone matrix by weight.

11. A bone graft substitute composition comprising:

(a) approximately 80-120 parts medical grade calcium sulfate hemihydrate by weight;

(b) approximately 21-250 parts sterile water by weight;

(c) approximately 1-40 parts carboxymethylcellulose by weight; and

(d) approximately 10-100 parts demineralized bone matrix by weight.

12. The bone graft substitute composition of any one of claims 1 to 11 , further comprising a bone allograft.

13. A method of making a bone graft substitute composition, the method comprising: providing a first composition comprising calcium sulfate, a cellulose derivative plasticizing agent and demineralized bone matrix; and contacting the first composition with a mixing solution to form the bone graft substitute composition.

14. The method of claim 13 , wherein the first composition further comprises a bone allograft.

15. The method of claim 13 , further comprising forming the bone graft substitute composition into a putty.

16. The method of claim 13 , wherein the calcium sulfate comprises calcium sulfate hemihydrate, the cellulose derivative comprises carboxymethylcellulose, and the mixing solution comprises sterile water.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Nov 19, 2020
From: MIDCAP FUNDING IV TRUST
To: SOLANA SURGICAL, LLC; ORTHOPRO, L.L.C.; WRIGHT MEDICAL GROUP N.V.; WRIGHT MEDICAL GROUP, INC.; BIOMIMETIC THERAPEUTICS CANADA, INC.; BIOMIMETIC THERAPEUTICS, LLC; BIOMIMETIC THERAPEUTICS USA, INC.; INBONE TECHNOLOGIES, INC.; ORTHOHELIX SURGICAL DESIGNS, INC.; TORNIER US HOLDINGS, INC.; TORNIER, INC.; TROOPER HOLDINGS INC.; WHITE BOX ORTHOPEDICS, LLC; WRIGHT MEDICAL CAPITAL, INC.; WRIGHT MEDICAL TECHNOLOGY, INC.; WRIGHT MEDICAL GROUP INTELLECTUAL PROPERTY, INC.
Reel/Frame 054480/0001 →
RELEASE OF SECURITY INTEREST Recorded Jan 13, 2017
From: JPMORGAN CHASE BANK, N.A., SUCCESSOR IN INTEREST TO THE CHASE MANHATTAN BANK, N.A.
To: WRIGHT MEDICAL TECHNOLOGY, INC.
Reel/Frame 040966/0398 →
SECURITY INTEREST Recorded Jan 5, 2017
From: WRIGHT MEDICAL TECHNOLOGY, INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 041257/0126 →